Rural Health
Resources by Topic: Illicit drug use
Pennsylvania Mobile Team Addresses Substance Use Disorders
Features the Addiction Recovery Mobile Outreach Team (ARMOT) program, which supports patients in the recovery process and educates medical staff on addiction and recovery. ARMOT is a collaboration of three hospitals, two substance abuse providers, and the Armstrong-Indiana-Clarion Drug and Alcohol Commission.
Author(s): Allee Mead
Citation: Rural Monitor
Date: 11/2016
Sponsoring organization: Rural Health Information Hub
view details
Features the Addiction Recovery Mobile Outreach Team (ARMOT) program, which supports patients in the recovery process and educates medical staff on addiction and recovery. ARMOT is a collaboration of three hospitals, two substance abuse providers, and the Armstrong-Indiana-Clarion Drug and Alcohol Commission.
Author(s): Allee Mead
Citation: Rural Monitor
Date: 11/2016
Sponsoring organization: Rural Health Information Hub
view details
The Criminal Justice Experience of African American Cocaine Users in Arkansas
Examines associations between the involvement in the criminal justice system and drug use in urban and rural African American cocaine users in Arkansas between 2010 and 2012. Includes demographic statistics by gender, age, rurality, and route of administration.
Author(s): Nickolas Zaller, Ann M. Cheney, Geoffrey M. Curran, Brenda M. Booth, Tyrone F. Borders
Citation: Substance Use & Misuse, 51(12), 1566-1576
Date: 10/2016
view details
Examines associations between the involvement in the criminal justice system and drug use in urban and rural African American cocaine users in Arkansas between 2010 and 2012. Includes demographic statistics by gender, age, rurality, and route of administration.
Author(s): Nickolas Zaller, Ann M. Cheney, Geoffrey M. Curran, Brenda M. Booth, Tyrone F. Borders
Citation: Substance Use & Misuse, 51(12), 1566-1576
Date: 10/2016
view details
Rural Opioid Use Disorder Treatment Depends on Family Physicians
Brief description of a study examining distribution of physicians approved to prescribe buprenorphine for opioid use disorder, by specialty and rurality. Features breakdowns by family medicine, emergency medicine, internal medicine, psychiatry, and all other specialties, and by urban or rural location.
Author(s): Peter Wingrove, Brian Park, Andrew Bazemore
Citation: American Family Physician, 94(7), 546
Date: 10/2016
Sponsoring organization: Robert Graham Center
view details
Brief description of a study examining distribution of physicians approved to prescribe buprenorphine for opioid use disorder, by specialty and rurality. Features breakdowns by family medicine, emergency medicine, internal medicine, psychiatry, and all other specialties, and by urban or rural location.
Author(s): Peter Wingrove, Brian Park, Andrew Bazemore
Citation: American Family Physician, 94(7), 546
Date: 10/2016
Sponsoring organization: Robert Graham Center
view details
Opioid Addiction: Laws, Regulations, and Other Factors Can Affect Medication-Assisted Treatment Access
Examines current federal laws and regulations related to the medication-assisted treatment (MAT) of opioid dependency, and discusses how these laws affect access to treatment, including in rural areas. Also explores other factors that affect access to treatment such as cost, insurance coverage, practitioner availability, and perceived value. Provides detailed descriptions about the uses and concerns of the three medications currently approved by the FDA for use in opioid MAT - methadone, buprenorphine, and naltrexone.
Additional links: Full Report
Date: 09/2016
Sponsoring organization: Government Accountability Office
view details
Examines current federal laws and regulations related to the medication-assisted treatment (MAT) of opioid dependency, and discusses how these laws affect access to treatment, including in rural areas. Also explores other factors that affect access to treatment such as cost, insurance coverage, practitioner availability, and perceived value. Provides detailed descriptions about the uses and concerns of the three medications currently approved by the FDA for use in opioid MAT - methadone, buprenorphine, and naltrexone.
Additional links: Full Report
Date: 09/2016
Sponsoring organization: Government Accountability Office
view details
Results from the 2015 National Survey on Drug Use and Health: Detailed Tables
Provides data on use of illicit drugs, alcohol, and tobacco, trends in substance use disorder and mental health, and access to treatment for youth 12-17 and adults. Features statistics for a variety of demographic and geographic characteristics.
Date: 09/2016
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Provides data on use of illicit drugs, alcohol, and tobacco, trends in substance use disorder and mental health, and access to treatment for youth 12-17 and adults. Features statistics for a variety of demographic and geographic characteristics.
Date: 09/2016
Sponsoring organization: Substance Abuse and Mental Health Services Administration
view details
Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014
Reports on drugs testing positive for fentanyl. Provides information on synthetic opioid-involved deaths other than methadone, including fentanyl deaths. For 27 states with death certificate reporting of drugs involved in overdoses, provides data for metropolitan, micropolitan, and noncore areas.
Author(s): R. Matthew Gladden, Pedro Martinez, Puja Seth
Citation: MMWR (Morbidity and Mortality Weekly Report), 65(33), 837-843
Date: 08/2016
Sponsoring organization: Centers for Disease Control and Prevention
view details
Reports on drugs testing positive for fentanyl. Provides information on synthetic opioid-involved deaths other than methadone, including fentanyl deaths. For 27 states with death certificate reporting of drugs involved in overdoses, provides data for metropolitan, micropolitan, and noncore areas.
Author(s): R. Matthew Gladden, Pedro Martinez, Puja Seth
Citation: MMWR (Morbidity and Mortality Weekly Report), 65(33), 837-843
Date: 08/2016
Sponsoring organization: Centers for Disease Control and Prevention
view details
Talking Rural Opioid Use at the United Nations: Q&A with Holly Andrilla
An interview with rural health researcher Holly Andrilla of the WWAMI Rural Health Research Center, recounting her experience presenting to the United Nations Office of Drugs and Crime in Vienna, Austria. Provides an international perspective on substance abuse prevention and treatment.
Author(s): Zachary Toliver
Citation: Rural Monitor
Date: 08/2016
Sponsoring organization: Rural Health Information Hub
view details
An interview with rural health researcher Holly Andrilla of the WWAMI Rural Health Research Center, recounting her experience presenting to the United Nations Office of Drugs and Crime in Vienna, Austria. Provides an international perspective on substance abuse prevention and treatment.
Author(s): Zachary Toliver
Citation: Rural Monitor
Date: 08/2016
Sponsoring organization: Rural Health Information Hub
view details
HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015
Examines the scope and source of an outbreak of human immunodeficiency virus (HIV) infection due to a single HIV type 1 (HIV-1) strain in a small rural community in Indiana. Discusses how prescription opioid analgesic abuse and the injection of drugs has contributed to the rapid spread of the Hepatitis C virus (HCV) and HIV. Describes how contact tracing was used to develop control measures and offers several recommendations on how to prevent similar outbreaks in the future.
Author(s): Philip J. Peters, Pamela Pontones, Karen W. Hoover, et al.
Citation: New England Journal of Medicine, 375, 229-239
Date: 07/2016
view details
Examines the scope and source of an outbreak of human immunodeficiency virus (HIV) infection due to a single HIV type 1 (HIV-1) strain in a small rural community in Indiana. Discusses how prescription opioid analgesic abuse and the injection of drugs has contributed to the rapid spread of the Hepatitis C virus (HCV) and HIV. Describes how contact tracing was used to develop control measures and offers several recommendations on how to prevent similar outbreaks in the future.
Author(s): Philip J. Peters, Pamela Pontones, Karen W. Hoover, et al.
Citation: New England Journal of Medicine, 375, 229-239
Date: 07/2016
view details
Families in Crisis: The Human Service Implications of Rural Opioid Misuse
Presents findings and policy recommendations from the National Advisory Committee on Rural Health and Human Services' 2016 meeting with rural residents, healthcare providers, and stakeholders regarding the impact and effects of opioid use disorders on rural families. Topics addressed include drug overdose and death, conflict with partners and children, emotional disturbance, adverse health risks, and related impacts on employment and economic sustainability.
Date: 07/2016
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
Presents findings and policy recommendations from the National Advisory Committee on Rural Health and Human Services' 2016 meeting with rural residents, healthcare providers, and stakeholders regarding the impact and effects of opioid use disorders on rural families. Topics addressed include drug overdose and death, conflict with partners and children, emotional disturbance, adverse health risks, and related impacts on employment and economic sustainability.
Date: 07/2016
Sponsoring organization: National Advisory Committee on Rural Health and Human Services
view details
On Pills and Needles: Counties Fight the Opioid Drug Crisis
Special issue focused on how counties are responding to the opioid crisis. Includes an interview with Michael Botticelli, director of the White House Office of National Drug Control Policy, focused on the federal response to rural opioid abuse.
Citation: County News
Date: 07/2016
Sponsoring organization: National Association of Counties
view details
Special issue focused on how counties are responding to the opioid crisis. Includes an interview with Michael Botticelli, director of the White House Office of National Drug Control Policy, focused on the federal response to rural opioid abuse.
Citation: County News
Date: 07/2016
Sponsoring organization: National Association of Counties
view details